Charles River Laboratories International Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Charles River Laboratories International Inc in the third quarter 2026?
Charles River Laboratories International inc achieved a return on average equity (ROE) of 1.35 % in its third quarter 2026, which is below Charles River Laboratories International Inc 's average return on equity, which stands at 10.49%.

ROE has advanced compared to -7.64% in the second quarter 2026, due to net income growth.

Within the Medical Laboratories industry 15 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 2505 to 2563.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 26 2026) III. Quarter	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter
Y / Y Equity Change	-5.23 %	-15.29 %	-7.93 %	-8.57 %	-
Y / Y Net Income Change	499.52 %	-	-	-	-20.97 %
Net Income (TTM) in Millions	41	-236	-183	-142	-80
Return On Equity (TTM)	1.35 %	-7.64 %	-5.68 %	-4.33 %	-2.37 %
CRL's Total Ranking	# 2563	# 2505	# 1559	# 2226	#
Equity (TTM) in Millions	3,232	2,846	2,946	3,170	3,410
Seq. Equity Change	13.57 %	-3.41 %	-7.05 %	-7.05 %	1.51 %
Seq. Net Income Change	-	-	-	-	5.43 %

Back to CRL Management Effectiveness >> CRL's 5 Years Annual ROE >> Compare CRL ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 16
Sector	# 223
Overall	# 2563

Return On Equity Statistics
High	Average	Low
21.46 %	10.49 %	-44.48 %
(Dec 26 2015)		(Sep 24 2011)

CRL Annual Return On Equity	(Dec 27 2025) 2025	(Dec 28 2024) 2024	(Dec 30 2023) 2023	(Dec 31 2022) 2022	(Dec 25 2021) 2021
Total Equity in Millions	3,170	3,467	3,602	2,981	2,539
Y / Y Equity Change	-8.57 %	-3.76 %	20.84 %	17.41 %	19.87 %
Net Income in Millions	-142	25	480	493	399
Y / Y Net Income Change	-	-94.74 %	-2.48 %	23.51 %	9.18 %
Return On Equity	-4.48 %	0.73 %	13.34 %	16.52 %	15.71 %

Back to CRL Management Effectiveness >> CRL's 5 Years Annual ROE >> Compare CRL ROE to its Competitors

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CRL's' Return on Equity at Yahoo Finance
CRL's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CRL's Competitors
Subscribers only: Roe for Charles River Laboratories International Inc 's Suppliers
Subscribers only: Return On Equity for CRL's Customers

Companies with similar Return On Equity at Sep 26 2026, within Healthcare Sector	ROE
Icu Medical Inc	2.81 %
Biogen Inc	1.86 %
Integra Lifesciences Holdings Corp	1.24 %

Date modified: 2026-11-05T14:33:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.